ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 177 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q4 2016. The put-call ratio across all filers is 0.97 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $11,876,000 | -27.4% | 168,915 | -26.8% | 1.49% | -27.5% |
| Q3 2016 | $16,361,000 | -1.0% | 230,628 | -31.7% | 2.06% | -12.3% |
| Q2 2016 | $16,521,000 | -13.3% | 337,788 | +12.2% | 2.34% | -6.8% |
| Q1 2016 | $19,062,000 | -17.7% | 301,091 | +45.8% | 2.52% | -7.6% |
| Q4 2015 | $23,172,000 | +16.3% | 206,559 | -0.2% | 2.72% | +17.9% |
| Q3 2015 | $19,925,000 | -25.0% | 206,880 | -20.3% | 2.31% | -14.4% |
| Q2 2015 | $26,584,000 | – | 259,633 | – | 2.70% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 497,899 | $31,617,000 | 3.20% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 390,453 | $24,794,000 | 1.81% |
| First Light Asset Management, LLC | 180,017 | $11,431,000 | 1.59% |
| Rock Springs Capital Management LP | 580,000 | $36,830,000 | 1.33% |
| Capital Impact Advisors, LLC | 36,165 | $2,244,000 | 0.82% |
| SECTOR GAMMA AS | 79,653 | $5,058,000 | 0.81% |
| Verity Asset Management, Inc. | 7,193 | $457,000 | 0.51% |
| Opus Point Partners Management, LLC | 5,064 | $322,000 | 0.48% |
| Capital International Sarl | 52,000 | $3,302,000 | 0.46% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 6,216 | $394,000 | 0.43% |